Hepatic Impairment Clinical Trials in San Antonio

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Pharmacokinetics of Sotorasib in Healthy Participants and Participants With Moderate or Severe Hepatic Impairment - 2022
Completed
  • Hepatic Impairment
  • Tustin, California
  • +4 more
2022-04-01
Apr 1, 2022
G
A Single-dose, Open-label, Pharmacokinetic Study of Belapectin (GR-MD-02) in Subjects With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment - 2022
Completed
  • Hepatic Impairment
  • Rialto, California
  • +3 more
2022-03-24
Mar 24, 2022
C
An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)
Recruiting
  • Primary Biliary Cholangitis
  • +2 more
  • Seladelpar 10 mg
  • Seladelpar 10 mg or less
  • Sacramento, California
  • +5 more
2022-03-18
Mar 18, 2022
J
A Study of JNJ-53718678 in Participants With Hepatic Impairment
Recruiting
  • Hepatic Impairment
  • Orlando, Florida
  • +1 more
2022-03-15
Mar 15, 2022
K
KD025 Hepatic Impairment Study With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment
Recruiting
  • Hepatic Impairment
  • Rialto, California
  • +4 more
2022-03-08
Mar 8, 2022
T
A Study of Soticlestat in Adults With Liver Failure Compared to Those With Normal Liver Function
Recruiting
  • Hepatic Impairment
  • Healthy Volunteers
  • Edgewater, Florida
  • +5 more
2022-03-03
Mar 3, 2022
A
A Study to Investigate the Effect of Mild and Moderate Hepatic Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Hepatic Function - 2021
Completed
  • Hepatic Impairment
  • Healthy Volunteers
  • Clearwater, Florida
  • +3 more
2022-03-02
Mar 2, 2022
N
Pharmacokinetic (PK) and Safety Study of Iptacopan (LNP023) in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Matched Control Healthy Participants With Normal Hepatic Function.
Recruiting
  • Hepatic Impairment
  • San Antonio, Texas
    Novartis Investigative Site
2022-02-07
Feb 7, 2022
A
A Study to Evaluate ASP0367 in Participants With Mild/Moderate Hepatic Impairment Compared to Participants With Normal Hepatic Function - 2022
Completed
  • Hepatic Impairment
  • Healthy Volunteers
  • Miami, Florida
  • +2 more
2022-02-04
Feb 4, 2022
N
Study to Assess the Pharmacokinetics of Pelacarsen (TQJ230) in Participants With Mild Hepatic Impairment Compared to Matched Healthy Participants
Recruiting
  • Hepatic Impairment
  • Morehead City, North Carolina
  • +1 more
2021-12-14
Dec 14, 2021
B
A Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986263 in Participants With Varying Degrees of Liver Impairment - 2021
Completed
  • Hepatic Impairment
  • San Antonio, Texas
    The Texas Liver Institute
2021-10-29
Oct 29, 2021
Z
Hepatic Impairment, Cholestatic Liver Disease, & NASH With Advanced Fibrosis & Normal Hepatic Function
Recruiting
  • Hepatic Impairment
  • Saroglitazar Magnesium 2 mg
  • Saroglitazar Magnesium 4 mg
  • Indianapolis, Indiana
  • +1 more
2021-07-25
Jul 25, 2021
N
PK and Safety of Midostaurin in Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function - 2020
Completed
  • Hepatic Impairment
  • San Antonio, Texas
  • +6 more
2021-05-08
May 8, 2021
D
Study of Single-dose DS-3201b in Participants With Hepatic Impairment - 2021
Completed
  • Hepatic Impairment
  • Miami, Florida
  • +2 more
2021-02-24
Feb 24, 2021
N
Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function - 2014
Completed
  • Solid Tumors
  • Hepatic Impairment
  • Los Angeles, California
  • +11 more
2020-12-17
Dec 17, 2020
K
Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major Metabolite - 2020
Completed
  • Hepatic Impairment
  • Miami, Florida
  • +2 more
2020-12-11
Dec 11, 2020
M
Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects
Recruiting
  • Hepatic Impairment
  • +2 more
  • Orlando, Florida
  • +2 more
2020-12-01
Dec 1, 2020
C
Evaluate the Pharmacokinetics of CC-220 in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared With Healthy Subjects - 2019
Completed
  • Hepatic Impairment
  • Healthy Volunteers
  • Miami, Florida
  • +2 more
2020-07-23
Jul 23, 2020
C
A Study to Assess the Pharmacokinetics of CC-90001 in Subjects With Mild, Moderate, and Severe Hepatic Impairment Compared With Healthy Subjects - 2019
Completed
  • Hepatic Impairment
  • Miami, Florida
  • +3 more
2020-07-23
Jul 23, 2020
A
A Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic Function - 2017
Completed
  • Hepatic Impairment
  • Knoxville, Tennessee
  • +1 more
2019-05-17
May 17, 2019
S
A Safety Study of Tucatinib in Healthy and Hepatically-Impaired Subjects - 2019
Completed
  • Hepatic Impairment
  • Tustin, California
  • +3 more
2019-05-16
May 16, 2019
A
A Single Dose Study of Oral Vadadustat in Subjects With Normal and Impaired Hepatic Function - 2018
Completed
  • Hepatic Impairment
  • Saint Paul, Minnesota
  • +1 more
2019-03-20
Mar 20, 2019
L
Study to Evaluate the Pharmacokinetics of Telotristat Ethyl in Subjects With Severe Hepatic Impairment - 2018
Completed
  • Hepatic Impairment
  • Telotristat Ethyl
  • Miami, Florida
  • +2 more
2018-10-11
Oct 11, 2018
B
A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants
Withdrawn
  • Hepatic Impairment
  • Miami, Florida
  • +2 more
2017-02-02
Feb 2, 2017
I
Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects - 2013
Completed
Has Results
  • Hepatic Failure
  • +2 more
  • Hialeah, Florida
  • +2 more
2016-09-09
Sep 9, 2016